ACE Inhibitors, ARBs Cut Mortality in PD Patients

Share this content:

Peritoneal dialysis (PD) patients treated with ACE inhibitors or angiotensin receptor blockers (ARBs) have a 62% reduced risk of death compared with PD patients not treated with these medications, after adjusting for age, BP, and other variables, according to a report in Nephrology Dialysis Transplantation (2008; published online ahead of print).

 

In the study, which was conducted at the University of Toronto, 165 PD patients were treated with ACE inhibitors or ARBs and 141 were not.

 

Investigators followed patients from the date of PD initiation until death, cessation of PD, transfer to other centers, or the end of the study.

You must be a registered member of Renal and Urology News to post a comment.